The short-term use of nebulized 3% HS did not result in any statistically significant benefits, although a nonsignificant trend toward a decrease in admission rate and improvement in respiratory distress was found. A larger study would be required to determine whether these trends arise from a clinically relevant treatment effect.
Laaya SabriN. AmiriKeyvan Forooraghi
Ahad TavakoliAlireza MonajatiR. Moini
Bing BaiJungang MiaoFengqin Lee
Dong‐Jin JungJonathan HansenKai Chang
Wenwei ChenQiong‐Sen WuXiao Zhang